Immunome Inc (IMNM) — Financial Flexibility Index
Immunome Inc (IMNM) has a Financial Flexibility Index of -0.90x as of December 2025. Free cash flow of $-43.95 Million (operating CF $-47.95 Million minus capex $4.00 Million) represents -1% of total liabilities ($48.84 Million). Also explore IMNM shareholders equity momentum to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Immunome Inc Financial Flexibility Index (2018–2025)
Historical Financial Flexibility Index trend for Immunome Inc across 8 annual periods. Check IMNM capital-intensive asset ratio to assess the company's strategic physical and investment asset allocation.
Annual Financial Flexibility Index for Immunome Inc (2018–2025)
Year-by-year free cash flow to debt coverage for Immunome Inc. For the full company profile including market capitalisation, see Immunome Inc (IMNM) market capitalisation.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -3.71x | $-181.23 Million | $-190.92 Million | $48.84 Million | ▼ -282.6% |
| 2024 | -0.97x | $-57.29 Million | $-110.79 Million | $59.08 Million | ▼ -312.5% |
| 2023 | -0.24x | $-6.74 Million | $-7.57 Million | $28.66 Million | ▲ +93.9% |
| 2022 | -3.85x | $-28.44 Million | $-28.69 Million | $7.39 Million | ▼ -106.5% |
| 2021 | -1.86x | $-18.15 Million | $-18.23 Million | $9.74 Million | ▲ +48.7% |
| 2020 | -3.63x | $-11.55 Million | $-12.13 Million | $3.18 Million | ▼ -1477.5% |
| 2019 | -0.23x | $-9.37 Million | $-9.60 Million | $40.69 Million | ▲ +4.9% |
| 2018 | -0.24x | $-7.18 Million | $-7.41 Million | $29.65 Million | — |